A John Camm

A John Camm

Professor of Clinical Cardiology

St George’s University of London, UK

  • LinkedIn
  • Twitter
  • Radcliffe

Biography

John Camm is British Heart Foundation Professor of Clinical Cardiology (Emeritus) at St George’s University of London, London, UK. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, and anticoagulation.

Professor Camm is Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine and ESC CardioMed, Electrophysiology of the Heart, Clinical Cardiology and Evidence Based Cardiology.  He has written or edited more than 40 books, predominantly in the field of cardiac arrhythmology. He has authored or co-authored more than 1450 peer reviewed papers, more than 500 book chapters, and in excess of 2500 accepted abstracts.  He has delivered more than 1000 international lectures.

Professor Camm has been involved in the production of numerous guidelines, including the ESC guidelines for the management of atrial fibrillation

Articles

Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy

C Fielder Camm, A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2017;6(2):63–8.

Letter from the New President of the European Heart Rhythm Association

A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2017;6(3):107.

A Clinical Perspective on Sudden Cardiac Death

Demosthenes G Katritsis, Bernard J Gersh, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review 2016;5(3):177–82

Anticoagulation in Atrial Fibrillation – Current Concepts

Demosthenes G Katritsis, Bernard J Gersh, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review 2015;4(2):100–7

Early Repolarisation Syndrome – New Concepts

Demosthenes G Katritsis, Bernard J Gersh, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review 2015;4(3):169–71

Inherited Arrhythmias – Where do we Stand?

A John Camm, Bernard J Gersh, Demosthenes G Katritsis, et al

Citation: Arrhythmia & Electrophysiology Review 2014;3(2):80–4

Stroke Prevention in Atrial Fibrillation – Outcomes and Future Directions

Katrina Mountfort, A John Camm, Gregory YH Lip, et al

Citation: Arrhythmia & Electrophysiology Review 2014;3(3):194–200

The Role of Continuous Monitoring in Atrial Fibrillation Management

A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2014;3(1):48-50

Stroke Prevention in Atrial Fibrillation - The Unmet Need and Morbidity Burden

A John Camm,

Citation: European Cardiology 2011;7(3):187–95

Considerations for the Development of New Antiarrhythmic Drugs

A John Camm, Craig Pratt, Silvia Priori, et al

Citation: European Cardiology 2010;6(2 Suppl):3–7

Epidemiology and Economic Burden of Atrial Fibrillation

A Bajpai, A John Camm, I Savelieva, et al

Citation: US Cardiology 2007;4(1):14–7

Antidotes or Reversibility Agents – Are they Needed?

A John Camm,

Published:

Citation: Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):6-7

Once or Twice-daily NOAC Therapy – Theory and Practice

A John Camm,

Published:

Citation: Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):5

Keywords

cardiac arrhythmia, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, myocardial infarction, heart failure, cardiomyopathy